AACR StoriesThe Faces & Voices Behind the Science
Preventing cancer and identifying malignancies at the earliest, most treatable stages are key areas of focus for the American Association for Cancer Research (AACR) and its members.
Using funding from the AACR, early-career investigator Marco Ruella, MD, found a way to improve immunotherapy for B-cell acute lymphoblastic leukemia.
Learn MoreValerie O’Brien, PhD, is using her microbiology expertise to model and study gastric cancer development with early support from a Debbie’s Dream Foundation-AACR grant.
Learn MorePioneering chemist and Fellow of the AACR Academy Carolyn R. Bertozzi, PhD, leads efforts to develop cancer therapeutics against “a different type of drug target.”
Learn MoreChemtai Mungo is researching an innovative self-treatment strategy for cervical precancer could save lives of women in underserved areas.
Your donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
